Orally administered adsorbent
The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention i...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
20.07.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention is an orally administered adsorbent comprising activated carbon fiber, wherein the orally administered adsorbent is a drug for treating or preventing kidney disease, or a drug for treating or preventing dialysis complications. |
---|---|
AbstractList | The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or removal performance, whereby a toxic substance inside the body can be adsorbed or removed rapidly and in large quantity. The present invention is an orally administered adsorbent comprising activated carbon fiber, wherein the orally administered adsorbent is a drug for treating or preventing kidney disease, or a drug for treating or preventing dialysis complications. |
Author | Shimazaki, Kenji Ohtaki, Akihito Imaizumi, Keiichiro Eto, Nobuaki Murakami, Takashi Nishiwaki, Yasumi |
Author_xml | – fullname: Ohtaki, Akihito – fullname: Nishiwaki, Yasumi – fullname: Murakami, Takashi – fullname: Imaizumi, Keiichiro – fullname: Eto, Nobuaki – fullname: Shimazaki, Kenji |
BookMark | eNrjYmDJy89L5WSQ9S9KzMmpVEhMyc3MyywuSS1KTQFyivOLklLzSngYWNMSc4pTeaE0N4OKm2uIs4duakF-fGpxQWJyal5qSbxjqJGBoZGxoaWJpamTk5ExkcoApvcnkg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | AU2012319495BB2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_AU2012319495BB23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:36:41 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_AU2012319495BB23 |
Notes | Application Number: AU20120319495 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170720&DB=EPODOC&CC=AU&NR=2012319495B2 |
ParticipantIDs | epo_espacenet_AU2012319495BB2 |
PublicationCentury | 2000 |
PublicationDate | 20170720 |
PublicationDateYYYYMMDD | 2017-07-20 |
PublicationDate_xml | – month: 07 year: 2017 text: 20170720 day: 20 |
PublicationDecade | 2010 |
PublicationYear | 2017 |
RelatedCompanies | TEIJIN LIMITED |
RelatedCompanies_xml | – name: TEIJIN LIMITED |
Score | 3.1039572 |
Snippet | The purpose of the present invention is to provide an orally administered adsorbent comprising activated carbon fiber having high adsorption performance or... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBONFILAMENTS CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS,THREADS, FIBRES, BRISTLES OR RIBBONS CHEMISTRY COMPOUNDS THEREOF HUMAN NECESSITIES HYGIENE INORGANIC CHEMISTRY MEDICAL OR VETERINARY SCIENCE METALLURGY NATURAL OR ARTIFICIAL THREADS OR FIBRES NON-METALLIC ELEMENTS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPINNING TEXTILES |
Title | Orally administered adsorbent |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170720&DB=EPODOC&locale=&CC=AU&NR=2012319495B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JS8NAFH6UKupNq-IW6aHkFpykyaQ5FDEbRbAp0kpvZWYyASG0JYmI_943Q6o96W0WeLPAW76ZtwAMPBqMmMuo5RQjBCh2jnJQCNeSniwCpvwuhPbyndLJwn1eessOlLtYGJ0n9FMnR0SOEsjvjZbX299HrFj7VtYP_B2HNo_pfBybLTq2feI7xIzDcTLL4iwyowiRpDl9VXNoyQQIB0IU2AdoSPvKASx5C1VcynZfqaSncDhDeuvmDDpy3YPjaFd7rQdHL-2XNzZb7qvPwcgqVpZffdYmvFVlNrFTbyqOZC5gkCbzaGLhOqufY62eFnubCp3hJXQR8csr6AsibeHLgkhWuLTImePKgORMcm5Tng-vwfiT1M0_87dwou5KPVE65A66TfUhDdStDb_XV_INe-h81A |
link.rule.ids | 230,309,783,888,25578,76884 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1JS8NAFH6UKtabVsUt2kPJLThJsx6KmKQhapsUSaW3MEkmUAhtSSLiv_dNSLUnvc0CbxZ4yzfzFoChplsmVakuKbmJAEXOUA6mqSoxjeUW5X4XaePlG-j-Qn1ZassOFLtYmCZP6GeTHBE5KkV-rxt5vf19xHIb38rqIVnh0ObRi8au2KJj2SCGQkTXHk_moRs6ouMgkhSDNz6HloyFcMBGgX2ARrbJM-1P3m0el7LdVyreCRzOkd66PoUOW_eh5-xqr_XhaNZ-eWOz5b7qDISwpEXxNaBtwlteZhM71aZMkMw5DL1J5PgSrhP_HCt-WuxtylZGF9BFxM8uYZASJqcGywmjuarnGVVUZpGMsiSR9SQbXYHwJ6nrf-bvoedHs2k8fQ5eb-CY3xt_rlTILXTr8oMJqGfr5K65nm991n_E |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Orally+administered+adsorbent&rft.inventor=Ohtaki%2C+Akihito&rft.inventor=Nishiwaki%2C+Yasumi&rft.inventor=Murakami%2C+Takashi&rft.inventor=Imaizumi%2C+Keiichiro&rft.inventor=Eto%2C+Nobuaki&rft.inventor=Shimazaki%2C+Kenji&rft.date=2017-07-20&rft.externalDBID=B2&rft.externalDocID=AU2012319495BB2 |